ABIONYX Pharma SA (EPA:ABNX)
France
· Delayed Price · Currency is EUR 3.890
0.00 (0.00%)
At close: Dec 5, 2025
ABIONYX Pharma Revenue
ABIONYX Pharma had revenue of 2.12M EUR in the half year ending June 30, 2025, a decrease of -0.42%. This brings the company's revenue in the last twelve months to 4.33M, down -10.91% year-over-year. In the year 2024, ABIONYX Pharma had annual revenue of 4.55M, down -1.92%.
Revenue (ttm)
4.33M
Revenue Growth
-10.91%
P/S Ratio
31.18
Revenue / Employee
84.82K
Employees
51
Market Cap
134.89M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.93B |
| Sartorius Stedim Biotech | 2.95B |
| bioMérieux | 4.12B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 6.02M |
| Virbac | 1.43B |